National Institute of Allergy and Infectious Diseases to Grant Exclusive Patent License to Butantan for Zika Vaccine Production

Summary

The National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, Department of Health and Human Services, is considering granting an exclusive patent license to Butantan, a Brazilian biotechnology company, to manufacture monovalent live attenuated Zika vaccines and multivalent live attenuated Zika and dengue vaccines.